Enjaymo

Generic name:sutimlimab-jome
Dosage form: injection, for intravenous use
Drug class:Selective immunosuppressants

Medically reviewed by Judith Stewart, BPharm. Last updated on Feb 7, 2022.

What is Enjaymo?

Enjaymo is a prescription medicine used to decrease the need for red blood cell transfusion due to the breakdown of red blood cells (hemolysis) in adults with cold agglutinin disease (CAD).

It is not known if this medicine is safe and effective in children.

Important information

Enjaymo can cause serious side effects, including:

Serious infections. Enjaymo is a prescription medicine that affects your immune system. Enjaymo can lower the ability of your immune system to fight infections. People who take Enjaymo may have an increased risk of getting infections caused by certain kinds of bacteria such as Neisseria meningitides, Streptococcus pneumoniae, and Haemophilus influenzae. These infections may be serious or life-threatening. Some infections may quickly become lifethreatening or cause death if not recognized and treated early.

• You need to receive vaccinations against infections caused by certain kinds of bacteria at least 2 weeks before your first dose of Enjaymo. You may need to have additional vaccinations during treatment.
• If your healthcare provider decides that urgent treatment with Enjaymo is needed, you should receive vaccinations as soon as possible.
• Vaccinations may reduce the risk of these infections, but do not prevent all infections. Call your healthcare provider or get medical help right away if you get any new signs and symptoms of an infection, including:
  • fever
  • severe headache with stiff neck or back
  • pain during urination or urinating more often than usual
  • cough or difficulty breathing
  • flu-like symptoms
  • pain, redness or swelling of the skin

See Enjaymo side effects.

Who should not receive Enjaymo?

Do not receive Enjaymo if you are allergic to sutimlimab-jome or any of the ingredients. See the end of this page for a complete list of ingredients.

Before receiving Enjaymo

Before receiving treatment, tell your healthcare provider about all of your medical conditions, including if you:

• have a fever or infection, including a history of human immunodeficiency virus (HIV), hepatitis B, or hepatitis C.
• have an autoimmune disease such as systemic lupus erythematosus (SLE), also known as lupus.
• are pregnant or plan to become pregnant. It is not known if Enjaymo will harm your unborn baby.
• are breastfeeding or plan to breastfeed. It is not known if Enjaymo passes into your breast milk. You should talk to your healthcare provider about the best way to feed your baby during treatment.

What other drugs will affect Enjaymo?

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

Know the medicines you take. Keep a list of them to s..